Morgan Stanley
MS
Morgan Stanley
Financials Large Cap Updated Jan 2, 2026

Morgan Stanley took in $59.1B of revenue and still sells at 17.1x earnings.

If you own MS, your money rides on a bank that made $59.1B and manages $1.67T.

$179.76
Market cap ~$286B · 52-week range $83–$182
75
Composite
Our overall rating — combines growth, value, risk, and momentum
75
/ 100

Average

Combines growth, value, risk, and momentum factors into a single institutional-grade score.

What it is
Morgan Stanley advises, trades, and manages money through three businesses that produced $59.1B of annual revenue.
How it gets paid
Last year Morgan Stanley made $59.1B in revenue. Wealth Management was the main engine at $27.2B, or 46% of sales.
Why it's growing
Revenue grew 9.1% last year. To wit, rebounding investment banking activity and a robust showing from its equity business boosted its institutional securities arm.
What just happened
Morgan Stanley missed by 9.8% on EPS, with profit at $2.68 a share.
A+ balance sheet — rock-solid finances — built to survive anything
70/100 earnings predictability — reasonably predictable
17.1x trailing p/e — the market's not buying it — or you found a deal
2.3% dividend yield — cash in your pocket every quarter
5.5% return on capital — nothing to write home about
XVARY composite: 75/100 — average
Morgan Stanley advises, trades, and manages money through three businesses that produced $59.1B of annual revenue.
46% of 2024 revenue came from Wealth Management, or about $27.2B. That is client money the bank keeps billing every year. AUM (assets under management, client money the firm oversees) hit $1.67T, so leaving means moving your accounts, advisors, and history, not just clicking a button.
financials large-cap wealth-management asset-fees markets
$59.1B annual revenue · their business grew +9.1% last year
Institutional Securities
$26.6B
Wealth Management
$27.2B
Investment Management
$5.3B
Trading and advisory platform
Institutional Securities
$32.5B · 55% of revenue
it's the biggest segment at $32.5B, and 8% growth tells you capital markets and deal activity were supportive. this is still the earnings engine the street notices first.
largest segment
Advisor-led client franchise
Wealth Management
$20.7B · +11% growth
this $20.7B business grew faster than the trading arm. in plain English: more of Morgan Stanley's revenue is coming from clients who pay recurring fees, not from one hot quarter on a desk.
stability driver
Portfolio and fund management
Investment Management
$5.9B · 10% of revenue
it's the smallest segment at $5.9B, but 7% growth still matters. it adds more fee income to a company the market still thinks of as a bank first and a manager second.
fee income
$1.67T
AUM
AUM (assets under management, client money) is the fee base. More assets, more tolls.
$59.1B
annual revenue
This is the bank's top line. It is the amount flowing in before pay, legal bills, and bonuses.
17.1x
trailing p/e
P/E (price to earnings, what you pay for one dollar of profit) is 17.1x. That is not bargain-bin pricing for a bank.
2.3%
dividend yield
Dividend yield means cash paid to you each year. At 2.3%, you get paid while you wait.
A+
Strength
  • balance sheet grade A+ — near the highest rating possible
  • risk rank 2 — safer than 80% of stocks
  • price stability 65 / 100
  • long-term debt $331.7B (54% of capital)
  • net profit margin 20.0% — keeps 20 cents of every dollar in revenue
  • return on equity 15% — $0.15 profit for every $1 investors have put in
A+ with balance sheet grade and risk rank standing out. your money faces less risk here than at most public companies.

You invested $10000 in MS 3 years ago → it's now worth $23030.

The index would have given you $13920.

source: institutional data · total return
missed estimates
Morgan Stanley missed by 9.8% on EPS, with profit at $2.68 a share.
The supplied revenue figures conflict: EDGAR shows $44.1B for the latest quarter, while consensus shows $59.1B TTM. The clean signal is EPS at $2.68 versus $2.97 expected, a 9.8% miss.
$44.1B
revenue
$2.68
eps
n/a
n/a
the number that mattered
The $2.68 EPS print versus $2.97 expected is the cleanest read. That is a 9.8% miss, and this bank trades on fee rhythm more than one noisy quarter.
source: company earnings report, 2026

Get this snapshot in your inbox

This page, delivered free — plus weekly updates when the numbers change. Plain English, no spam.

Weekly updates Earnings alerts Plain English No spam

The top threat is repeat control failures inside capital-markets businesses. Morgan Stanley can absorb a fine. what you do not want is a pattern.

Med
Stock-loan antitrust settlement
Morgan Stanley was part of a $499M settlement with Goldman Sachs, JPMorgan, and UBS tied to pension-fund allegations around stock lending.
The cash hit is real, but the bigger issue is what it says about oversight in businesses that sell trust for a living.
Med
Block-trading enforcement
A January 2024 settlement required a $249M payment tied to criminal and regulatory investigations into block-trading practices.
Known cost: $249M. Less visible cost: repeat scrutiny can keep a quality multiple from expanding.
Med
Compensation pressure in a people business
The February 2026 SEC filing flagged regulatory and human-capital risks for 2025. For an advisory and trading franchise, talent retention is not overhead. It is the product.
Higher pay, weaker retention, or both would pressure the current 20.0% net margin.
the known bill is $748M. against the roughly $11.8B implied by a 20.0% margin on $59.1B of revenue, that is about 6% of annual profit — painful, not thesis-breaking.
Source: institutional data · regulatory filings · risk analysis
Earnings
Q1 2026 earnings report
April 15, 2026 is the next check-in. After a 10% beat, you want to see whether the strength still looks broad across segments.
Mix
Wealth management keeping the lead
wealth management grew 11% versus 8% for institutional securities. if that spread holds, the earnings profile gets less cyclical and the premium case stays alive.
Regulatory
Whether the settlements stay isolated
$748M of combined settlement costs is the known number. what matters next is whether that number stops growing.
Valuation
17.1x earnings near the high
the stock is sitting near its $182 high while trading at 17.1x trailing earnings. quality supports that. any slip in margins or mix leaves you less room for error.
earnings predictability
70 / 100
results are reasonably dependable, but trading and deal activity still move the numbers around. in human-speak: this is steadier than a pure investment bank, not as smooth as a fee-only manager.
price stability
65 / 100
the stock has held up well, but it still behaves like a financial. when investors get nervous about banks, they rarely stop to sort the good ones first.
xvary composite
75 / 100
above weak, below elite. you are looking at a strong franchise with a respectable setup, not a neglected bargain.
Source: institutional data

institutions have been net buying for 3 consecutive quarters — 1,051 buyers vs. 903 sellers in 3q2025. total institutional holdings: 1.3B shares. net buying for 3 quarters.

Source: institutional data
3-5 year target range
$137 $264
$180 Current price
$201 Target midpoint · +12% from current · 3-5yr high: $220 (+22% · 7% ann'l return)
source: institutional data · analyst targets

Want the deeper analysis?

The full deep dive: DCF model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.

See plans from $5/mo
MS
XVARY Deep Dive
ms
The full analysis is in the works.
What you'll get
DCF valuation model
Bull / base / bear scenarios
Competitive moat breakdown
Quarterly earnings tracker
Operating model projections
Risk matrix with kill criteria
Original price target + conviction
Updated with every earnings
Free · no spam · you'll be first to read it